T10631
|
|
|
Adrenergic Receptor
|
Bucindolol (BMY 13105) 是一种新型有效的 β1 肾上腺素能受体 (β1-adrenergic receptor) 阻滞剂,可介导血管舒张,可用于研究慢性心力衰竭。 |
T10631L
|
|
|
Adrenergic Receptor
|
Bucindolol Formate 是一种具有内源性拟交感活性的β1 肾上腺素能受体 (β1-adrenergic receptor) 阻滞剂。Bucindolol 可用于心力衰竭疾病研究。 |
T26920
|
|
|
|
Bucindolol is a beta-adrenergic receptor antagonist. Bucindolol is a fourth-generation β-blocker. Bucindolol prevented new-onset AF; β₁ and α(2c) polymorphisms predicted therapeutic response; and the 47% of patients who were β₁389 Arg homozygotes had an e |